visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    Yumanity Therapeutics

    Get Full Access

    Description

    • Yumanity Therapeutics is transforming drug discovery for neurodegenerative diseases caused by protein misfolding. Despite the fact that an estimated 50 million people worldwide suffer from diseases affecting the brain and central nervous system, there are no approved disease-modifying therapies or cures. Yumanity is working to identify and develop new, disease-modifying therapies that address several illnesses with critical unmet medical needs, including Alzheimers disease, Parkinsons disease and amyotrophic lateral sclerosis (ALS). The companys approach concentrates on correcting the cellular pathologies driven by misfolded proteins, the altered biology or phenotypes driving these diseases. Yumanity Therapeutics was founded in December 2014 by Susan Lindquist, Ph.D., award-winning protein folding expert, and Tony Coles, M.D., a renowned biotech industry leader. The companys proprietary platforms have already identified one potential new target for treating Parkinsons disease, and Yumanity is actively advancing its new chemical lead series for this condition, as well as identifying additional compounds for Alzheimers disease and ALS. Targeting the underlying protein pathology of neurodegenerative diseases allows the company to discover therapies that may modify the root cause of these rather than only addressing their symptoms. If you are interested in a career at Yumanity Therapeutics, please contact us at careers@yumanity.com.
    • location

      Headquarters:40 Guest Street Suite 4410, Boston, Massachusetts, United States

      More
    • Yumanity Therapeutics phone

      Phone Number: +1 617-409-5300

    • Yumanity Therapeutics website

      Website: https://www.yumanity.com

    • Yumanity Therapeutics employees

      Employees:42

    • Yumanity Therapeutics revenue

      Revenue:$50 - 100M

    • Yumanity Therapeutics legal name

      Legal Name:Yumanity Therapeutics

    • Yumanity Therapeutics's Social Media

      Yumanity Therapeutics linkedin Yumanity Therapeutics twitter
    • done Is this data correct?

    • |  NAICS Code: 541714  |

      Show More
    Person level website identification

    Chief Business Officer for Yumanity Therapeutics

    Paulash Mohsen

    Chief Business Officer

    Person level website visitor identification

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    Paulash Mohsen

    Chief Business Officer

    Michael Wyzga

    Chief Financial Officer

    Dan Tardiff

    Scientific Co-Founder And Vice President, Head Of Translational Research

    Tony Coles

    Chairman

    Marie Epstein

    Vice President Finance

    Frequently Asked Questions regarding Yumanity Therapeutics

    • Where are Yumanity Therapeutics's Headquarters?

      Yumanity Therapeutics's Headquarters are in 40 Guest Street Suite 4410,Boston,Massachusetts,United States

    • What is Yumanity Therapeutics's phone number?

      Yumanity Therapeutics's phone number is +1 617-409-5300

    • What is Yumanity Therapeutics's official website?

      Yumanity Therapeutics's official website is https://www.yumanity.com

    • What is Yumanity Therapeutics's Revenue?

      Yumanity Therapeutics's revenue is $50 - 100M

    • What is Yumanity Therapeutics's NAICS code?

      Yumanity Therapeutics's NAICS code is 541714

    • How many employees are working in Yumanity Therapeutics

      Yumanity Therapeutics has 42 employees

    • What is Yumanity Therapeutics's Industry?

      Yumanity Therapeutics is in the industry of Biotechnology

    • Who is Yumanity Therapeutics's Chief Business Officer?

      Yumanity Therapeutics's Chief Business Officer is Paulash Mohsen

    Company Directory